View in EDS HTML Full Text PDF Full Text

BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti‐CTLA‐4 treatment.

Saved in:

Bibliographic Details
Title:	BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti‐CTLA‐4 treatment.
Authors:	Tseng, Hsin‐Yi^1,2,3 (AUTHOR), Alavi, Sara^1,2,3 (AUTHOR), Gallagher, Stuart^1,2,3,4 (AUTHOR), McGuire, Helen M.^2,4,5 (AUTHOR), Hersey, Peter^2,3 (AUTHOR), Al Emran, Abdullah^1,2,6 (AUTHOR), Tiffen, Jessamy^1,3,4 (AUTHOR) jessamy.tiffen@sydney.edu.au
Source:	Pigment Cell & Melanoma Research. Nov2024, Vol. 37 Issue 6, p744-751. 8p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	17551471
DOI:	10.1111/pcmr.13174